STOCKRETAIL-DRUG STORES AND PROPRIETARY STORESUpdated 2026-06-07
Here’s whether CVS HEALTH CORPORATION (CVS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.65% over 10 days); RSI 50 — healthy momentum range; strong 1-year return of +52.1%; 3-month momentum positive (+22.6%). Currently 2.5% off its 52-week high. Score: +7/7.
CVS is in a confirmed uptrend, trading above both its 50-day ($84.07) and 200-day ($78.99) moving averages. An RSI of 50.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +52.1% compares to +24.4% for SPY (beat the market by 27.7%).
$10,000 invested 1 year ago→ $15,208 today
vs. S&P 500 (SPY) — same period beat market by 27.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($78.99)
✓Above 50-day MA ($84.07)
✓RSI(14) neutral zone (30–70) — currently 50.1
✓Positive return (+52.1%)
✓Within 10% of period high (−2.5%)
Period Range $95.93
$58.50$98.43
RSI (14) 50.1
0 · OversoldOverbought · 100
Key Metrics
Price$95.93
Period Return+52.1%
Period High$98.43
Period Low$58.50
Drawdown−2.5%
MA-50$84.07
MA-200$78.99
RSI (14)50.1
Avg Volume (30d)8.5M
vs. SPYbeat by 27.7%
Return Rank#337 of 1245
Trend Signals
Price is above the 200-day moving average ($78.99)